Symcel secures SK 5.6 million as further investment to fund marketing and business development initiatives

May 23, 2016

Application development of innovative calScreener™ technology continues apace as Symcel expands with move into larger, highly advanced premises   Symcel: 23 May 2016: Symcel, the company behind the revolutionary cell-based assay tool, calScreener™, has today announced that it has secured further investment with a value SK 5.6 million. The company’s existing owners were the source of all the latest funding.   The investment is earmarked for supporting Symcel’s on-going marketing activities and its business development initiatives, including developing applications with the backing of key industry opinion leaders (KOLs). The company’s strategy for expansion includes a move into new markets across ...

Read More

APTAR PHARMA’S PRESERVATIVE FREE MULTI-DOSE OPHTALMIC SQUEEZE DISPENSER LAUNCHED IN THE U.S.

May 13, 2016

Radolfzell, Germany – May 13, 2016 – Aptar Pharma, a global solution provider of innovative and proven aerosol, injection and spray delivery systems for biotech, healthcare and pharma products, has partnered with a leading eye care company to develop and launch a new eye drop product, which uses Aptar Pharma’s innovative preservative free multi-dose Ophthalmic Squeeze Dispenser (OSD). This is the first preservative free multi-dose eye drop featuring Aptar Pharma’s OSD in the United States. Following the worldwide trend towards safe, patient-friendly, cost-effective and preservative free multi-dose dispensers such as Aptar Pharma’s OSD system, the new over-the-counter (OTC) eye care ...

Read More

Aesica at the forefront of meeting industry demand for high value supply chain consolidation Quickening time to market with reliable, highly efficient end-to-end service capabilities

May 10, 2016

3 May 2016: Aesica Pharmaceuticals, the global pharmaceutical contract development and manufacturing organisation (CDMO), is one of the leading authorities within its industry to strategically embrace growing market demand for complete one-stop-shop service provision from providers with the foresight to heavily consolidate their supply chain. Such CDMOs are driving up the value of their services to customers – with operational strategies in place that enable the optimal performance and efficient delivery of everything from API manufacture, formulation development through to clinical batch and commercial scale manufacturing. Forward looking, end-to-end CDMO service providers, like Aesica Pharmaceuticals, are adding exceptional value to ...

Read More

Understand your SAR data at a glance

Apr 12, 2016

Activity Atlas from Cresset condenses your structure-activity data into highly visual 3D maps that inform the design and optimization of new compounds. The novel algorithms avoid the pitfalls of traditional 3D-QSAR to produce highly visual maps that enhance new compound design. With Activity Atlas you will: Know where to focus future optimization efforts Increase the productivity of your team Focus new molecule design towards novelty and activity Gain seamless communication of complex SAR data between research groups. Read more about Activity Atlas or see it applied in case studies on selectivity of A2a antagonists or converting patent data into 3D ...

Read More

Flexibility by Design

Apr 12, 2016

Groninger introduces FlexPro 50, a modular turnkey machine concept for the aseptic filling and closing of Ready-To-Use vials, cartridges and syringes. As requirements have shifted from high speed filling lines towards the processing of significantly diverse biotech products in smaller batches, this market trend requires new solutions for aseptic processing. As a pharma-specialized machine building company, Groninger & Co. GmbH recently introduced the FlexPro 50, a modular filling and closing system designed to process Ready-To-Use vials, cartridges and syringes, as well as vials in bulk and trays. FlexPro 50 lines can be executed with manual or fully automated process steps ...

Read More